We are proud to be part of the solution to help fight the coronavirus that is changing our world. We are partnering with some of the largest and innovative pharmaceutical companies around the world to create vaccines and therapeutics. Globally, our clients are coming to us for assistance based on the trust and respect we’ve earned from our work in the marketplace. As an industry leader in the life sciences sector, we understand the degree and level of planning and the sense of urgency to develop innovative solutions to meet the challenges our clients face. Below are just a few examples of the project we are currently supporting to help in the fight against COVID-19.
|Operation Warp Speed
We proudly support the mission of Operation Warp Speed to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.
IPS is providing our expertise and consulting services to help increase the reliability of drug manufacturing in the US, in particular the APIs required for COVID-19 treatment and the medical devices to deliver the vaccine.
ApiJect has completely reimagined how to make and fill a new kind of prefilled injector that can deliver medicines and vaccines with enormous speed, scale, and efficiency.
ApiJect joined forces with the US government’s RAPID (Rapid Aseptic Packaging of Injectable Drugs) Consortium to mitigate “surge capacity” for a pandemic response using their blow-fill-seal prefilled syringes. ApiJect selected IPS as a key partner in the design and delivery of their facilities for surge manufacturing to prepare for the next pandemic.
More information can be found at www.apiject.com\partnerships
|Ireland COVID Alliance
We are proud to be a key member of Ireland’s COVID Alliance in response to the critical COVID-19 challenge.
IPS is part of a selected engineering team offering our extensive services to the Health Service Executive (HSE) as it prepared for the impact of COVID-19’s arrival in Ireland.
IPS was an integral member of the Alliance team with experienced design resources to complete the schedule-driven task. In less than 20 days, assessments were completed on over 30 hospital facilities across the country. In the end, the engineering assessments showed that almost all of the hospital medical gas systems were appropriate for the anticipated surge plan demand and modifications were only required at a few facilities.
Along with the organizations in the COVID Alliance from academic, industrial, business and professional society backgrounds, IPS is motivated by the desire to proactively assist in whatever way we can, and are driven by the motto:
‘Bi Ullamh – Ni neart go cur le cheile’ / ‘Be prepared – There is no strength without unity’.
Featured COVID-19 Experts
Paula Casalino, P.Eng.
VP, Operations, Canada
Sr. Compliance Consultant/Sr. Vice President Compliance
Daniel J. Colantonio, P.Eng.
Director of Project Management, Canada
Jason S. Collins, AIA
Director of Process Architecture
John M. Fay, PE
Sr. Process Engineer
Dushy Gnanapragasam, P.Eng.
Director of Process Engineering, Canada
Komal Hatti, NCARB, MBA
Director, Process Architect
Sterling G. Kline, RA
Aseptic Subject Matter Expert
Sr. Process Engineer
Leonard F. Pauzer
Director Drug Product Technologies
Thomas J. Piombino
Vice President, Biotechnology Process Architect
Mark E. Rezac, PE
Director, Compliance Services
Robert Roy, PE
Director, Aseptic Technology
Director, Process Engineering
Kevin Smyth, CEng, MIChemE
Global Director of Process Technology, GS&T
Carmella Tallarida, EIT
Lead Process Engineer
Paul F. Valerio
Director, Process Technology